Domov › Srdcové zlyhanie › Washington › Seattle
Klinické štúdie Srdcové zlyhanie v meste Seattle, WA
17 štúdií pre Srdcové zlyhanie hľadá účastníkov v zariadeniach v meste Seattle a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Prebieha náborFáza 3
- Virginia Mason Medical Center, Seattle
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Prebieha náborFáza 2
- Local Institution - 132, Seattle
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Prebieha náborFáza 2/3
- Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Prebieha náborFáza 2
- Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Prebieha náborObservačná štúdia
- Virginia Mason Medical Center, Seattle
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Prebieha náborFáza 3
- Tenax Investigational Site, Seattle
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Prebieha náborFáza 3
- Swedish Medical Center_Seattle, Seattle
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Prebieha náborFáza 2
- Seattle Children's Hospital, Seattle
Assessment of CCM in HF With Higher Ejection Fraction
Prebieha nábor
- Swedish Medical Center, Seattle
Repurposing Valsartan May Protect Against Pulmonary Hypertension
Prebieha náborFáza 2
- University of Washington Medical Center, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Prebieha náborFáza 3
- University of Washington, Seattle
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Prebieha nábor
- University of Washington Medical Center, Seattle
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
Prebieha nábor
- University of Washington, Seattle
Left vs Left Randomized Clinical Trial
Prebieha nábor
- University of Washington, Seattle
Cardiogenic Shock Working Group Registry
Prebieha náborObservačná štúdia
- University of Washington Medical Center, Seattle
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Prebieha náborFáza 1/2
- University of Washington Medicine, Seattle
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Prebieha nábor
- University of Washington Medical Center, Seattle
Štúdie Srdcové zlyhanie v iných mestách
- New York City, NY51 štúdií
- Boston, MA44 štúdií
- Dallas, TX42 štúdií
- Houston, TX36 štúdií
- Cleveland, OH33 štúdií
- Chicago, IL31 štúdií
- Philadelphia, PA31 štúdií
- San Francisco, CA29 štúdií
- St. Louis, MO26 štúdií
- Durham, NC26 štúdií
- Kansas City, MO25 štúdií
- Atlanta, GA25 štúdií
Iné štúdie v Seattle
- Nemalobunkový karcinóm pľúc53 štúdií
- Rakovina (všetky typy)49 štúdií
- Rakovina prostaty42 štúdií
- Akútna myeloidná leukémia40 štúdií
- Rakovina prsníka39 štúdií
- Metastatická rakovina39 štúdií
- Kolorektálny karcinóm34 štúdií
- Rakovina pľúc33 štúdií
- Rakovina vaječníkov30 štúdií
- Mnohonásobný myelóm22 štúdií
- Myelodysplastické syndrómy21 štúdií
- Akútna lymfoblastová leukémia21 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.